Ultrasound-guided Lavage of Calcific Deposits of the Rotator Cuff
Launched by SCHULTHESS KLINIK · Feb 22, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a procedure called ultrasound-guided lavage, which is a way to clean out calcific deposits in the shoulder that can cause pain and limit movement. Specifically, the study aims to see how well this technique works for patients with rotator cuff tendinitis, a condition that often leads to pain in the upper arm and shoulder, especially when lifting the arm or at night. Researchers will monitor changes in ultrasound images to understand how the calcific deposits and the tendon itself are healing over time, as well as how patients feel after the treatment.
To be eligible for this trial, participants must be at least 18 years old and have pain in their shoulder due to a specific type of calcific deposit. They should have already tried other treatments, like physical therapy and anti-inflammatory medication, without improvement. It's also important that participants can understand the study information in German and agree to take part. Those with certain other shoulder issues or previous treatments in the last three months may not qualify. If you join this study, you can expect to receive the ultrasound-guided lavage treatment and follow-up assessments to track your recovery and symptoms.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient aged 18 years and older
- • Pain in the deltoid region worsening with activities above shoulder level and/or at night with a calcific deposit
- • Ultrasound evaluation of the calcific deposit with type I or II characteristics, a solitary conformation, a minimum size of 1.0 x 0.5 x 0.4cm (length x width x depth) and without clear signs of resorption (PDUS grade 0 - I°, see study procedure).
- • In case of multiple calcific deposits, it has to be warranted that the other deposits are smaller than the minimum size of 1.0 x 0.5 x 0.4cm and with no signs of PDUS signals.
- • Qualification for more intensive treatment on account of no clinical improvement after a minimum of 3 months with conservative treatment (physical therapy and oral anti-inflammatory drugs).
- • able to understand the content of the patient information / consent form in German and give consent to take part in the project
- Exclusion Criteria:
- • Previous UGPL or surgery of the affected shoulder
- • Treatment with subacromial injection (SAI) or ESWT in the three months before inclusion
- • Other causes of shoulder complaints (e.g. rotator cuff tear, frozen shoulder, inflammatory arthritis, bursitis, ...)
- • Intervention failure (no retrieval of calcific material, leakage of the injected saline, disruption of the calcific rim or distribution of calcific material)
- • Patients with a language barrier hindering questionnaire completion
- • Pregnancy
About Schulthess Klinik
Schulthess Klinik is a renowned medical institution based in Zurich, Switzerland, specializing in orthopedic surgery and rehabilitation. With a commitment to advancing patient care through innovative research and clinical trials, the clinic is dedicated to enhancing treatment outcomes and improving quality of life for individuals with musculoskeletal conditions. Schulthess Klinik combines state-of-the-art technology with a multidisciplinary approach, fostering collaborations among healthcare professionals to ensure comprehensive care and support for patients. Its reputation for excellence in clinical research positions Schulthess Klinik as a leader in the field, contributing valuable insights to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zürich, , Switzerland
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials